OTOGL: Potential Drug Target and Biomarker (G283310)

Target Name: OTOGL

NCBI ID: G283310

OTOGL

OTOGL: Potential Drug Target and Biomarker

OTOGL, Otogelin-like protein precursor, is a protein that is found in the cells of many organisms, including humans. It is a small protein that is made up of 21 amino acids, and it is often referred to as OTOGL-like protein or simply as OTOGL. While OTOGL is not a well-known protein, research into its potential uses as a drug target or biomarker has been conducted in recent years.

One of the main reasons for the interest in OTOGL is its potential as a drug target. OTOGL is known to be involved in several cellular processes that are important for the development and maintenance of tissues, including the development of blood vessels, the regulation of cell growth, and the development of tissues such as muscles and bones. As such, OTOGL has been shown to be a potential drug target for a variety of diseases, including cancer, heart disease, and neurological disorders.

One of the key advantages of OTOGL as a drug target is its small size and the ease with which it can be modified to fit into different applications. This has made it possible for researchers to test the effects of different drugs on OTOGL without the need for large, complex experiments. Additionally, the fact that OTOGL is a protein that is found in many organisms has made it easier for researchers to study its effects in a wide range of organisms, including humans.

Another potential use of OTOGL as a drug target is its potential as a biomarker. OTOGL has been shown to be involved in several cellular processes that are important for the development and maintenance of tissues, including the development of blood vessels. As such, OTOGL has been shown to be a potential biomarker for a variety of diseases, including heart disease and cancer.

In addition to its potential as a drug target and biomarker, OTOGL has also been shown to be involved in several other cellular processes that are important for the development and maintenance of tissues. For example, OTOGL has been shown to be involved in the regulation of cell adhesion, the development of tissues such as muscles and bones, and the regulation of the immune response.

While OTOGL is still a relatively little-known protein, research into its potential uses as a drug target and biomarker has been conducted in recent years. As these studies continue, it is likely that the role of OTOGL in the development and maintenance of tissues will become more clear, and its potential as a drug target and biomarker will continue to be explored.

Overall, OTOGL is a protein that has the potential to be a drug target and biomarker, and further research is needed to fully understand its role in the development and maintenance of tissues. While its potential uses are still being explored, the small size and ease of modification make it a promising molecule for further study.

Protein Name: Otogelin Like

The "OTOGL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OTOGL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets